Home Cart Sign in  
Chemical Structure| 1927857-56-4 Chemical Structure| 1927857-56-4

Structure of PQR620
CAS No.: 1927857-56-4

Chemical Structure| 1927857-56-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

PRQ620 is a highly potent and selective mTORC1/2 inhibitor, shows anti-tumor effects in vitro and in vivo.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of PQR620

CAS No. :1927857-56-4
Formula : C21H25F2N7O2
M.W : 445.47
SMILES Code : NC1=NC=C(C2=NC(N3[C@@]4([H])COC[C@]3([H])CC4)=NC(N5[C@@]6([H])COC[C@]5([H])CC6)=N2)C(C(F)F)=C1
MDL No. :MFCD30489733
InChI Key :UGDKPWVVBKHRDK-KPWCQOOUSA-N
Pubchem ID :122412735

Safety of PQR620

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of PQR620

PI3K-AKT

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
BEAS-2B cells 300 nM 48 hours PQR620 did not significantly inhibit cell viability or induce apoptosis activation in BEAS-2B cells. Front Oncol. 2021 Jun 10;11:669518
NCI-H1944 cells 300 nM 48 hours PQR620 significantly inhibited viability, proliferation, and migration in NCI-H1944 cells. Front Oncol. 2021 Jun 10;11:669518
A549 cells 300 nM 48 hours PQR620 significantly inhibited viability, proliferation, and migration in A549 cells. Front Oncol. 2021 Jun 10;11:669518
PNSCLC-1 cells 30-1000 nM 48 hours PQR620 decreased viability in pNSCLC-1 cells in a concentration-dependent manner, significantly inhibiting cell growth, proliferation, migration, and invasion, while inducing significant apoptosis activation. Front Oncol. 2021 Jun 10;11:669518
Lymphoma cell lines 250 nM 72 hours To evaluate the anti-tumor activity of PQR620 in lymphoma cell lines, showing a median IC50 of 250 nM, primarily cytostatic. Cancers (Basel). 2019 Jun 4;11(6):775

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
NOD-Scid mice ABC-DLBCL RI-1 cell line xenograft model Oral 100 mg/kg Once daily for 21 days To assess the in vivo anti-lymphoma activity of PQR620, showing a significant decrease in tumor volumes compared to controls from day 12 (p<0.05). Cancers (Basel). 2019 Jun 4;11(6):775
SCID mice NSCLC xenograft model Oral 30 mg/kg Daily for 21 days PQR620 oral administration significantly inhibited NSCLC xenograft growth in SCID mice, with no apparent toxicities detected. Front Oncol. 2021 Jun 10;11:669518

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.24mL

0.45mL

0.22mL

11.22mL

2.24mL

1.12mL

22.45mL

4.49mL

2.24mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories